Literature DB >> 1700647

Artificial matrix barriers: a diffusion study utilizing dextrans and microspheres.

B Persky1, M J Hendrix.   

Abstract

Eight artificial matrices (AMs) were evaluated for the ability to restrict the passage of diffusion probes. Three AMs were composed exclusively of interstitial type I collagen (Col I) and differed from each other in thickness only. Four AMs consisted of reconstituted basement membrane (RBM) -coated polycarbonate filters (containing 10 microns diameter pores) and also only differed in thickness. One AM consisted of an uncoated 10 microns pore polycarbonate filter. The diffusion probes were uncharged fluorescein isothiocyanate-labeled dextrans, having molecular weights of 17,900, 42,000, 71,200, and 148,900 and negatively charged latex microspheres, having diameters of 0.08, 0.30, and 0.95 microns. Probes were applied to the AMs, incubated for 72 hr at 37 degrees C, and then analyzed spectrophotometrically. Dextran passage was increasingly restricted for Col I matrices as either molecular weight or collagen thickness increased (range 7% to 0.7%). Thin RBM-coated filters were more permeable to dextrans (range 100% to 30%) than Col I matrices. The diffusion rate of microspheres for Col I matrices (range 3.5% to 0) was similar to both thick and thin RBM-coated filters (range 4% to 0). The uncoated filter permitted the most diffusion for both dextrans and microspheres (range 100% to 7%). These data demonstrate that the AMs presented in this study will allow direct observation of the degradative and migratory potential of cells in vitro as they interact with various extracellular matrices.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700647     DOI: 10.1002/ar.1092280104

Source DB:  PubMed          Journal:  Anat Rec        ISSN: 0003-276X


  1 in total

1.  Cell-penetrating HIV1 TAT peptides can generate pores in model membranes.

Authors:  Corina Ciobanasu; Jan Peter Siebrasse; Ulrich Kubitscheck
Journal:  Biophys J       Date:  2010-07-07       Impact factor: 4.033

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.